Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John A Lupisella

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Seminars in Immunology|March 12, 2022
Formyl peptide receptor 2 and heart diseaseJohn A Lupisella, Pravin S Shirude, Nicholas R Wurtz, et al.
The Journal of Rheumatology|February 4, 2003
Inhibition of disease progression by a novel retinoid antagonist in animal models of arthritisBlake C Beehler, Yong-Jiang Hei, Simon Chen, et al.
Endocrinology|September 30, 2006
Pharmacological and x-ray structural characterization of a novel selective androgen receptor modulator: potent hyperanabolic stimulation of skeletal muscle with hypostimulation of prostate in ratsJacek Ostrowski, Joyce E Kuhns, John A Lupisella, et al.
ACS Medicinal Chemistry Letters|June 16, 2022
Discovery of Heteroaryl Urea Isosteres for Formyl Peptide Receptor 2 AgonistsNicholas R Wurtz, James A Johnson, Andrew Viet, et al.
EMBO Molecular Medicine|April 3, 2025
Formyl-peptide receptor type 2 activation mitigates heart and lung damage in inflammatory arthritisAndreas Margraf, Jianmin Chen, Marilena Christoforou, et al.
Journal of Medicinal Chemistry|December 22, 2006
Discovery of potent, orally-active, and muscle-selective androgen receptor modulators based on an N-aryl-hydroxybicyclohydantoin scaffoldChongqing Sun, Jeffrey A Robl, Tammy C Wang, et al.
ACS Medicinal Chemistry Letters|September 18, 2024
Discovery and Optimization of Aryl Piperidinone Ureas as Selective Formyl Peptide Receptor 2 AgonistsNicholas R Wurtz, Pravin S Shirude, Daniel L Cheney, et al.
Bioorganic & Medicinal Chemistry Letters|February 13, 2007
Tandem optimization of target activity and elimination of mutagenic potential in a potent series of N-aryl bicyclic hydantoin-based selective androgen receptor modulatorsLawrence G Hamann, Mark C Manfredi, Chongqing Sun, et al.
JACC. Basic to Translational Science|January 8, 2020
Preservation of Post-Infarction Cardiac Structure and Function via Long-Term Oral Formyl Peptide Receptor Agonist TreatmentRicardo A García, Bruce R Ito, John A Lupisella, et al.
Plos One|February 6, 2013
11β-hydroxysteroid dehydrogenase type 1 gene knockout attenuates atherosclerosis and in vivo foam cell formation in hyperlipidemic apoE⁻/⁻ miceRicardo A García, Debra J Search, John A Lupisella, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Seminars in Immunology|March 12, 2022
Formyl peptide receptor 2 and heart diseaseJohn A Lupisella, Pravin S Shirude, Nicholas R Wurtz, et al.
The Journal of Rheumatology|February 4, 2003
Inhibition of disease progression by a novel retinoid antagonist in animal models of arthritisBlake C Beehler, Yong-Jiang Hei, Simon Chen, et al.
Endocrinology|September 30, 2006
Pharmacological and x-ray structural characterization of a novel selective androgen receptor modulator: potent hyperanabolic stimulation of skeletal muscle with hypostimulation of prostate in ratsJacek Ostrowski, Joyce E Kuhns, John A Lupisella, et al.
ACS Medicinal Chemistry Letters|June 16, 2022
Discovery of Heteroaryl Urea Isosteres for Formyl Peptide Receptor 2 AgonistsNicholas R Wurtz, James A Johnson, Andrew Viet, et al.
EMBO Molecular Medicine|April 3, 2025
Formyl-peptide receptor type 2 activation mitigates heart and lung damage in inflammatory arthritisAndreas Margraf, Jianmin Chen, Marilena Christoforou, et al.
Journal of Medicinal Chemistry|December 22, 2006
Discovery of potent, orally-active, and muscle-selective androgen receptor modulators based on an N-aryl-hydroxybicyclohydantoin scaffoldChongqing Sun, Jeffrey A Robl, Tammy C Wang, et al.
ACS Medicinal Chemistry Letters|September 18, 2024
Discovery and Optimization of Aryl Piperidinone Ureas as Selective Formyl Peptide Receptor 2 AgonistsNicholas R Wurtz, Pravin S Shirude, Daniel L Cheney, et al.
Bioorganic & Medicinal Chemistry Letters|February 13, 2007
Tandem optimization of target activity and elimination of mutagenic potential in a potent series of N-aryl bicyclic hydantoin-based selective androgen receptor modulatorsLawrence G Hamann, Mark C Manfredi, Chongqing Sun, et al.
JACC. Basic to Translational Science|January 8, 2020
Preservation of Post-Infarction Cardiac Structure and Function via Long-Term Oral Formyl Peptide Receptor Agonist TreatmentRicardo A García, Bruce R Ito, John A Lupisella, et al.
Plos One|February 6, 2013
11β-hydroxysteroid dehydrogenase type 1 gene knockout attenuates atherosclerosis and in vivo foam cell formation in hyperlipidemic apoE⁻/⁻ miceRicardo A García, Debra J Search, John A Lupisella, et al.
Pageof 2